Pricing Log in Create free account

MoonLake Immunotherapeutics (MLTX) vs Odyssey Therapeutics, Inc. (ODTX)

MoonLake Immunotherapeutics and Odyssey Therapeutics, Inc. are both Biotechnology companies. MoonLake Immunotherapeutics and Odyssey Therapeutics, Inc. are of similar size ($919.2M and $907.3M). Across the 8 metrics below, Odyssey Therapeutics, Inc. leads on 5 and MoonLake Immunotherapeutics on 3.

Valuation

Metric MLTX ODTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 1.98 2.44 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (33.42%) (90.93%) (32.88%)
Free cash flow yield (26.52%) (16.19%) (23.13%)

Profitability

Metric MLTX ODTX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (67.08%) 0.00% (51.96%)
Return on assets (51.00%) 0.00% (46.06%)
Return on invested capital 0.00% (238.81%) 0.00%

Growth

Metric MLTX ODTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (86.77%) — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MLTX ODTX Biotechnology median
Debt to equity 0.23 0.00 0.00
Current ratio 12.56 12.94 4.97
Net debt to EBITDA 1.32 — 1.01

Dividend

Metric MLTX ODTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MLTX ODTX Biotechnology median
Market cap 919.15m 907.34m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack